Using self-healing materials in commercial applications requires healing chemistry that is cost-effective, widely available and tolerant of moderate temperature excursions. We investigate the use of tungsten (VI ) chloride as a catalyst precursor for the ring-opening metathesis polymerization of exo-dicyclopentadiene (exo-DCPD) in self-healing applications as a means to achieve these goals. The environmental stability of WCl 6 using three different delivery methods was evaluated and the associated healing performance was assessed following fracture toughness recovery protocols. Both as-received and recrystallized forms of the WCl 6 resulted in nearly complete fracture recovery in self-activated tests, where healing agent is manually injected into the crack plane, at 12 wt% WCl 6 loading. In situ healing using 15 wt% microcapsules of the exo-DCPD produced healing efficiencies of approximately 20%.
INTRODUCTION
Self-healing materials are inspired by many biological examples in which the healing process is triggered, regulated and completed in an autonomic fashion. For structural applications, the healing of bone ( Fratzl 2007) serves as a rich source of concepts of functional adaptation in response to damage and stress state. How these concepts are being integrated in synthetic materials was also the subject of a recent special issue on this topic ).
Several techniques for achieving self-healing functionality in polymer materials have been demonstrated. These approaches include the incorporation of microcapsules ( White et al. 2001) or hollow glass fibres containing healing agent (Pang & Bond 2005) ; the use of a microvascular network to deliver healing agent throughout a structure (Toohey et al. in press ); using reversible cross-linking to induce mending after heating via molecular linkages (Chen et al. 2002) ; and a phaseseparated system based on polydimethylsiloxane (Cho et al. 2006) . Self-healing occurs when monomer is released and initiated by an embedded catalyst phase (White et al. 2001; Toohey et al. in press) or when a two-part resin system is released simultaneously in the crack plane (Pang & Bond 2005) . Healing efficiencies of over 90% have been achieved for in situ samples with a healing chemistry that uses benzylidene-bis(tricyclohexylphosphine)dichlororuthenium (Grubbs' catalyst) to initiate ring-opening metathesis polymerization (ROMP) of the endo isomer of dicyclopentadiene (DCPD; Brown et al. 2002) . Mauldin et al. (2007) explored ROMP using the exo isomer of DCPD and Grubbs' catalyst and found that healing reached steady state approximately 20 times faster when compared with endo-DCPD, but at the expense of a maximum achievable healing efficiency (approximately 60% of that reached for the endo-DCPD). Although Grubbs' catalyst has a nearly ideal chemical selectivity, its high cost, restricted availability and limited temperature stability preclude its use in high volume, commercial composite and polymeric parts.
Alternative catalyst precursors for ROMP healing have been surveyed (Rule 2005) , and tungsten (VI ) chloride (WCl 6 ) with a co-activator was identified to have the greatest potential to address many of the limitations previously indicated. WCl 6 is a costeffective alternative that is widely available and has a melting point of T m Z2758C, which is significantly higher than that of Grubbs' catalyst (T m Z1538C). The commercial potential of this class of tungsten catalyst systems has been demonstrated in the Metton (Metton America, Inc.) liquid moulding two-part resin system based on the ROMP of endo-DCPD (Breslow 1990) .
In catalyst systems based on WCl 6 , the WCl 6 itself is not the active catalyst, but rather a catalyst precursor. A key step in forming an active catalyst is the alkylation of the tungsten, and this is usually accomplished by the addition of a separate co-activator. In controlled environments (i.e. no air or impurities are present), the most effective co-activators are aggressive alkylating agents such as organoaluminium compounds (Breslow 1990 ), but they are also extremely sensitive to air and other impurities. This sensitivity makes them inappropriate for self-healing in an air environment. Therefore, as a more stable alkylating agent, we chose to use phenylacetylene, which has been shown to be an effective co-activator with WCl 6 even in air (Katz & Han 1982) . In formulating this self-healing system, we also include nonylphenol as a dissolution agent (Breslow 1990 ). This component is necessary because self-healing is triggered by the dissolution of the catalyst into the healing agent (DCPD), and without nonylphenol, WCl 6 is nearly insoluble in DCPD.
It is also worth noting that the air environment of the self-healing reaction is expected to affect the WCl 6 . A probable initial oxidation product is WOCl 4 , which is also a ROMP-active catalyst (Balcar et al. 1992) . Furthermore, WOCl 4 has been claimed to be a necessary component (in addition to the WCl 6 ) for effective catalysis (Breslow 1990) . Therefore, for the purpose of this work, we consider both WCl 6 and any WOCl 4 generated by oxidation to be active catalyst precursors.
We report on the viability of WCl 6 as a ROMP active catalyst precursor for self-healing polymers. Environmental stability of this catalyst precursor was evaluated using UV-visible (UV-vis) absorbance spectrophotometry with three different WCl 6 delivery methods. The healing performance associated with each delivery method was evaluated by fracture experiments. The use of a coupling agent to increase the virgin (initial) fracture toughness was explored, as well as the effect of WCl 6 dispersion and concentration on healing performance.
MATERIAL AND METHODS

WCl 6 delivery methods
WCl 6 is sensitive to both moisture and the processing environment of curing epoxy resins (Rule 2005) . In addition to as-received WCl 6 (Aldrich), recrystallized and a wax-protected form of WCl 6 were prepared for use in self-healing epoxy. The morphology of as-received WCl 6 is shown in figure 1a. The average particle sizes determined by analysis of scanning electron microscope (SEM) images for all three delivery methods are listed in table 1.
The recrystallized and wax-protected WCl 6 were prepared in a nitrogen-filled glove box or using standard Schlenk techniques (Shriver & Drezdzon 1986 ). Recrystallized WCl 6 was prepared according to the procedure outlined by Ketelaar & van Oosterhout (1943) . WCl 6 (18.0 g) was placed in a sealed heavywalled flask with 200 ml of dry CCl 4 (Aldrich) and heated to 1208C in an oil bath. After 30 min, heating was stopped and the sample was left to cool slowly. The resulting mixture was filtered and the WCl 6 particles were dried under vacuum. The product was then sieved and particles smaller than 180 mm were used for chemical and mechanical testing. Recrystallized WCl 6 morphology (figure 1b) shows a high aspect ratio planar geometry, in contrast to the as-received form. The crystal structures of both the as-received and recrystallized WCl 6 were confirmed by X-ray diffraction to be the hexagonal a-WCl 6 polymorph (Ketelaar & van Oosterhout 1943) .
A third delivery method was investigated in which the as-received WCl 6 was dissolved and dispersed in a paraffin wax bead in order to provide protection from potential deactivation by amines during curing of the epoxy matrix. A similar protection scheme was used by Rule et al. (2005) for Grubbs' catalyst. WCl 6 (5.25 g) was added to a 40 ml vial with 730 mg of the dissolution agent nonylphenol (Aldrich) and 9.0 g of paraffin wax (melting point of 58-628C, Aldrich). The dissolution agent was added to compatibilize the WCl 6 with the wax beads and to facilitate dissolution in the DCPD healing agent. The vial was capped and placed in a 1208C bath and magnetically stirred. In a separate bath, 300 ml of dry perfluorodecalin (Flutec PP6, F2 Chemicals) was stirred at 1250 r.p.m. with a mechanical mixer in a 1000 ml beaker until it reached a temperature of 658C. Upon complete melting of the wax, the sample mixture was poured into the perfluorodecalin bath and allowed to stir for 1 min. Approximately 700 ml of chilled perfluorodecalin was quickly added to the hot perfluorodecalin bath to quench the suspension and solidify the wax beads. The perfluorodecalin and wax mixture was vacuum filtered and the wax beads (figure 1c) were dried under vacuum. The beads were then sieved and the beads smaller than 355 mm were kept for further study. Elemental analysis of the wax beads revealed that the concentration of tungsten was 10 wt%, while the theoretical tungsten concentration based on the mixture ratio was 16%. After processing, a dense solid remained in the vial suggesting incomplete dissolution of the WCl 6 had occurred.
Assessment of environmental stability
Environmental stability of the three forms of WCl 6 was monitored using UV-visible absorbance spectrophotometry. Samples exposed to air (228C, 30% relative humidity) for 0, 2 or 24 h were brought into an argonfilled glove box and dissolved in dry toluene at a concentration of 0.8 mM of tungsten. The UV-vis absorbance spectra were taken at wavelengths from 280 to 800 nm in quartz cuvettes (path length of 0.1 cm) with Teflon seals.
Sample preparation
Tapered double-cantilever beam (TDCB) fracture specimens (Brown et al. 2002) were adopted to evaluate healing performance. The tapered geometry allows for a crack length-independent fracture toughness measurement. Localized TDCB specimens, as shown in figure 2, were manufactured using Epon 828 epoxy resin (Miller-Stephenson) cured with 12 pph Ancamine DETA (Air Products). Since the crack is directed along the centreline of the specimens, only the material near the centreline is used during self-healing. Therefore, the sample was made in two stages such that only the material near the centreline possesses self-healing functionality. A method developed by Rule et al. (2007) was used in which a non-self-healing blank was formed in the outer regions of the TDCB geometry by pouring neat resin epoxy into a silicon rubber mould that contained a 7 mm wide insert around the grooved section of the sample. The blanks used for in situ samples also contained microcapsules at the same concentration as the centre material. Rule et al. (2007) found that the measured fracture toughness was artificially high for in situ samples with no capsules in the blank. However, by incorporating the same concentration of microcapsules in the blank, the modulus and thermal expansion coefficient are matched with the self-healing centre and accurate fracture toughness data are obtained. The blank was then cured for 24 h at 228C. The insert was subsequently removed and the selfhealing material was prepared for the second stage of specimen manufacturing. Two types of samples were fabricated: self-activated and in situ. Self-activated samples contained WCl 6 , but no healing agent and in situ samples contained both WCl 6 and microencapsulated DCPD (Brown et al. 2002) . Epoxy resin was degassed and allowed to react for 30 min prior to the addition of WCl 6 to permit time for the viscosity of the resin to increase (preventing settling of WCl 6 particles) and reduce the concentration of free amines. The desired amount of WCl 6 was then added to the epoxy resin. Higher concentrations of wax-encapsulated WCl 6 (more than 20 wt%) were not possible due to excessive viscosity of the resin mixture. Unless otherwise stated, samples were mixed by hand. The effect of WCl 6 dispersion was investigated by comparing hand-mixed and mechanically mixed samples.
For in situ self-healing samples, microcapsules were also added to the mixture at this time. These microcapsules contained exo-DCPD, phenylacetylene (45 mM) and nonylphenol (45 mM) and were manufactured by an established interfacial polymerization encapsulation technique (Brown et al. 2003) . The resulting capsules were sieved and the distribution used for analysis was 188G31 mm. The resin mixture was then poured into the centre of the blank and the mould was closed. All samples were cured for 24 h at 228C followed by an additional 24 h at 358C. The samples were removed from the moulds, allowed to cool to 228C and then tested.
Mechanical assessment of healing performance
TDCB fracture specimens were similar to those used by Rule et al. (2007) , but with a nominal crack width of 3.8 mm and an overall specimen thickness of 7.1 mm. The fracture toughness is determined as
where P c is the critical fracture load and a is a scaling parameter that depends on the specimen geometry and material properties and is equal to 8777 m K3/2 , which was calculated from Brown et al. (2002) data for the thicker samples used here. The healing efficiency was calculated as A new self-healing chemistry J. M. Kamphaus et al. 97 where P c virgin is the critical fracture load of the initial fracture and P c healed is the critical fracture load after healing.
Some samples exhibited a nonlinear response after healing. These experiments were analysed using a method outlined by Rule et al. (2005) which defines an alternative healing efficiency as
where A is the total area under the load-displacement curve; b n is the width of the crack plane (3.8 mm); W is the distance from the centre of the loading pins to the end of the specimen (79.3 mm); a 0 virgin is the initial crack length for the virgin test; and a 0 healed is the initial crack length for the healed test. Both h (the recovery of the linear-elastic fracture toughness) and h 0 (the recovery of the total fracture energy) are independent measures of healing efficiency and they cannot be directly compared.
The testing of the TDCB samples followed previously established protocols for self-activated samples where the samples contain the catalyst phase and the healing agent is manually injected into the crack (Brown et al. 2002) .
A small starter crack was initiated by tapping a razor blade into a moulded starter notch. The samples were pin loaded in Mode I using displacement control at 5 mm s K1 until complete failure. After the virgin (initial) test, the two pieces of the sample were brought back together in alignment while maintaining a small gap of approximately 1 mm between the crack faces. Approximately 100 ml of a healing solution was then injected between the crack faces. For samples containing wax-protected WCl 6 , the healing solution was prepared by mixing 5 ml of phenylacetylene (Aldrich) and 1 ml of exo-DCPD synthesized from endo-DCPD (Acros) (Nelson & Kuo 1975) . For samples containing as-received or recrystallized WCl 6 , 10 mg of nonylphenol, a dissolution agent, was added to the above-mentioned healing solution. The nonylphenol was omitted from the healing solution for wax-protected WCl 6 , as it is already present in the wax beads. Once the healing solution was injected, the crack faces were then brought into full contact and left undisturbed for 48 h. After healing, the samples were tested again without initiating another starter crack. wax-encapsulated delivery methods. For the as-received and recrystallized samples, a two-stage failure process was observed. Healed specimens exhibited an initial linear elastic response until reaching a critical fracture load after which a precipitous drop in load-carrying capability was observed. Continued deformation of the samples leads to a lengthy and gradual decline in load and a ductile-type failure mode that absorbs a significant amount of energy before final failure is achieved. During this second ductile failure stage, partially polymerized poly(DCPD) fibrils that bridge the crack plane provide a means of load transfer between the two halves of the sample ( figure 3b) .
In situ samples were tested in a similar fashion to the self-activated samples, but no additional healing agent was manually applied in these cases. Rather, healing agent delivery is accomplished autonomically via fracture of microcapsules contained within the sample. Figure 4 shows the UV-vis spectra for the different WCl 6 forms investigated. The initial spectra for the as-received and recrystallized compound are consistent with published results (Thorn-Csányi & Timm 1985) . After exposure to ambient air for 2 h, about half of the as-received WCl 6 remains, while the recrystallized WCl 6 has been completely converted to either WOCl 4 (as evidenced by the single peak at 355 nm reported by Thorn-Csányi & Timm (1985) ) or other non-absorbing or insoluble compounds. The spectra for the waxprotected WCl 6 are qualitatively different with a significant absorption band above 500 nm. Complexes of WCl 6 with phenols have been reported to have similar absorption spectra (Balcar et al. 1992) , so this suggests that the tungsten in the wax-protected catalyst exists as a complex with the nonylphenol that is added. The as-received WCl 6 retained some presumably active WOCl 4 after 24 h of exposure, while the recrystallized and wax-encapsulated forms retained no WCl 6 or WOCl 4 .
RESULTS
Environmental stability of WCl 6
Healing of the self-activated system
Self-activated tests were performed to demonstrate and refine the system. Specifically they were used to evaluate the effect of (i) WCl 6 delivery methods, (ii) a coupling agent on the virgin toughness, and (iii) the dispersion of the WCl 6 on the self-healing performance. Table 2 summarizes the results of these experiments.
Effect of WCl 6 delivery methods
Self-activated TDCB specimens with 4.4, 7 or 12 wt% of as-received or recrystallized WCl 6 were tested. The virgin and the initial portion of the healed loaddisplacement data for the 7 and 12 wt% samples were linear (figure 3a,b) and therefore satisfied the requirements for the use of equation (2.2). To account for the large amount of energy consumed in the second stage of failure of these samples, we also calculated healing efficiencies using equation (2.3) for all sample types. The 4.4 wt% samples containing recrystallized WCl 6 and a coupling agent exhibited a nonlinear healing response; therefore, equation (2.3) was used to quantify the healing efficiency. The polymerized healing agent was removed from the crack plane and analysed by A new self-healing chemistry J. M. Kamphaus et al. 99
Fourier transform infrared spectroscopy (FTIR). By monitoring the spectra and observing the characteristic peak at 965 cm K1 corresponding to the trans double bond for both the polymerized healing agent and an authentic poly(exo-DCPD) control, it was confirmed that the achieved healing was a result of ROMP of exo-DCPD.
Self-activated TDCB samples containing 20 wt% of wax-encapsulated WCl 6 (4.4 wt% overall catalyst loading) were also evaluated. A nonlinear healing response (figure 3c) was obtained and the healing efficiency was evaluated using equation (2.3). The nonlinearity upon healing in this case is probably due to either plasticization of the healed poly(DCPD) film by dissolved wax or to incomplete polymerization as a result of the lower effective catalyst concentration as was exhibited in the 4.4 wt% recrystallized catalyst samples.
Effect of coupling agent
A decrease in the virgin fracture toughness was observed for both the as-received and recrystallized WCl 6 samples as shown in table 2. In both cases, regardless of WCl 6 concentration, a large (approximately 50%) decrease in virgin fracture toughness occurs when compared with neat resin. The size, shape, concentration and bonding of the particles to the matrix were all considered as possible causes for the decrease in toughness, but poor interfacial bonding between the WCl 6 and epoxy matrix was thought to be the prevailing effect. There is precedence in the literature for a decrease in fracture toughness of polymers due to poor adhesion of inclusions (Maiti & Sharma 1992; Wong & Truss 1994; Brown et al. 2004) . Other factors such as particle shape, size, volume fraction and distribution may also decrease toughness (Lange & Radford 1971; Quazi et al. 1999) and may account for the difference between the neat resin samples and the WCl 6 samples containing coupling agent.
To confirm that poor interfacial bonding between the WCl 6 and matrix was the dominant cause of decreased fracture toughness, a series of experiments were carried out with and without adhesion promoter. During manufacturing, 1 wt% of the silane coupling agent 3-glycidoxypropyltrimethoxysilane (Aldrich) was added to the epoxy resin prior to addition of the WCl 6 phase. A series of control samples with 1 wt% coupling agent, but no WCl 6 phase, were also tested.
Control experiments confirmed that the addition of coupling agent has no effect on the fracture toughness of the neat epoxy. More importantly, the addition of the coupling agent increased the toughness of the as-received and recrystallized WCl 6 samples almost to levels consistent with the neat epoxy samples. Scanning electron images comparing the fracture surfaces of samples with and without coupling agent are shown in figure 5 . Debonding between the WCl 6 and matrix phase is clearly evident in the sample without coupling agent and it is dramatically suppressed when the coupling agent is added. A subset of the self-activated samples containing coupling agent was tested and a representative load versus displacement response for these samples is shown in figure 6 . The healing for both types of WCl 6 delivery was unaffected by the addition of the coupling agent, as shown in table 2.
Effect of dispersion
The as-received form of the WCl 6 has a tendency to agglomerate into large particle clusters in the epoxy resin during processing and the lack of uniform dispersion leads to inconsistent healing. In order to obtain better dispersion, the as-received WCl 6 was incorporated in the epoxy resin using a mechanical mixer stirring at 500 r.p.m. prior to pouring into the moulds. SEM images of samples with and without mechanical mixing are compared in figure 7. Image analysis was performed to ascertain the relative level of clustering of the WCl 6 particles. A method outlined by Schwarz & Exner (1983) to characterize the clustering of points was implemented. The distance from the centroid of each cluster to its nearest neighbour was calculated. The mean and variance of the distribution of distances was calculated for samples with and without mechanical mixing as well as a random distribution from a Poisson point process with the same number of particles and image size as each sample image. The parameters Q and R were calculated as Deviation of Q or R from unity indicates some degree of clustering and was used to characterize the relative clustering between the two mixing conditions. Table 3 summarizes the results from this analysis. Both the Q and R values for the mechanically mixed sample deviated from unity by less than 7%. When no mechanical mixing was used, image analysis yielded QZ0.85 and RZ1.74, indicating significant clustering of catalyst particles. Interestingly, the healing efficiency of the well-dispersed WCl 6 samples dropped from 107 to 20% and the healing response was nonlinear, as shown in figure 8.
3.6. Self-healing of the in situ microencapsulated system
In situ healing experiments were performed with 12 wt% recrystallized WCl 6 and 15 wt% microcapsules that contained a healing solution of exo-DCPD, nonylphenol and phenylacetylene at the same concentrations as the self-activated healing solution. The healed samples exhibited a nonlinear fracture response, as shown in figure 9a , indicating incomplete polymerization of the poly(DCPD) film. Figure 9b shows a representative SEM image of the fracture surface after healing of an in situ sample. Broken microcapsules and poly(exo-DCPD) film are present on the fracture surface, indicating that mechanical triggering of the monomer release occurred. Healing efficiency calculated using equation (2.3) is 20%.
DISCUSSION
Self-activated TDCB experiments clearly demonstrate the effectiveness of WCl 6 as a catalyst precursor for selfhealing epoxy. Of the delivery methods examined, the as-received morphology retains the greatest activity upon exposure to laboratory air. The surface area to volume ratio of the particles may play an important role in the environmental stability of the particles. Table 1 shows the surface area to volume ratio for each of the three WCl 6 forms. The as-received and recrystallized forms have similar surface areas per unit volume, indicating that the difference in stability is not directly attributed to the surface area, but may be dictated by the smallest critical dimension. As the outer surface oxidizes, more of the WCl 6 remains active in the as-received particles with a larger critical dimension (27.8 mm) in comparison with the recrystallized particles with the smaller critical dimension (11.8 mm). Wax protection of the WCl 6 phase achieved mixed results-healing was obtained for effective WCl 6 concentrations that were lower than could be obtained by other delivery methods (4.4 wt%), but no healing activity could be detected after 24 h exposure to laboratory air. Inherently coupled with the deactivation problem, dispersion of the WCl 6 phase within the epoxy matrix plays an important role in the efficiency of healing. Healing activity is preserved via particle clusteringpresumably by sealing interior particles from exposure to the surrounding polymer matrix. When these clusters are broken up and dispersed through strong mechanical mixing, the healing efficiency dramatically decreases. Embedding the WCl 6 phase in wax leads to better dispersion while maintaining reasonable healing efficiency.
For the as-received and recrystallized delivery methods, more than 7 wt% WCl 6 loading was necessary to achieve complete healing. Some portion of the WCl 6 was deactivated during specimen manufacturing and curing. Hence, better protection schemes will enable lower tungsten loadings in the future. Even with the technical challenges identified, in situ healing was demonstrated (approx. 20%) using 12 wt% as-received WCl 6 and 15 wt% microcapsules containing exo-DCPD healing agent. More effective protection schemes for WCl 6 and other co-activators mixed with the healing agent are being examined for further enhancement of this self-healing system.
CONCLUSIONS
A cost-effective way to achieve self-healing was demonstrated using WCl 6 with a co-activator (phenylacetylene) that initiates ROMP of exo-DCPD. The environmental stability of three WCl 6 delivery methods was investigated by UV-vis spectrophotometry and the as-received form shows the greatest stability after 24 h exposure to laboratory air. Self-activated healing of TDCB fracture specimens showed nearly complete recovery for 12 wt% catalyst loading for both as-received and recrystallized WCl 6 , but strong mechanical mixing to promote dispersion of the catalyst reduced healing efficiency dramatically. The virgin fracture toughness of epoxy was reduced by approximately 48% upon addition of WCl 6 particles and this reduction was attributed to poor interfacial bonding. Incorporating a silane coupling agent into the matrix resin increased the virgin fracture toughness to approximately 75% of the neat resin toughness. Preliminary in situ healing experiments using 12 wt% as-received WCl 6 and 15 wt% 188 mm microcapsules containing exo-DCPD healing agent, 0.5 wt% phenylacetylene and 1.0 wt% nonylphenol yielded approximately 20% healing efficiency. Further research is required to optimize the healing efficiency by more effective WCl 6 protection schemes, more efficient co-activators and enhanced processing methods to achieve uniform WCl 6 dispersion.
